Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Risk of second malignancies after platinum-based chemotherapy of testicular cancer].

Literature DB >> 30564844

[Risk of second malignancies after platinum-based chemotherapy of testicular cancer].

David Utz¹, Arndt-Christian Müller².

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Platinum
Cisplatin

Year: 2019 PMID： 30564844 DOI： 10.1007/s00066-018-1410-3

Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

Authors: R Timothy D Oliver; Graham M Mead; Gordon J S Rustin; Johnathan K Joffe; Nina Aass; Robert Coleman; Rhian Gabe; Philip Pollock; Sally P Stenning
Journal: J Clin Oncol Date: 2011-01-31 Impact factor: 44.544

2. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).

Authors: T Tandstad; O Ståhl; O Dahl; H S Haugnes; U Håkansson; Å Karlsdottir; A Kjellman; C W Langberg; A Laurell; J Oldenburg; A Solberg; K Söderström; U Stierner; E Cavallin-Ståhl; R Wahlqvist; N Wall; G Cohn-Cedermark
Journal: Ann Oncol Date: 2016-04-06 Impact factor: 32.976

3. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

Authors: Torgrim Tandstad; Rune Smaaland; Arne Solberg; Roy M Bremnes; Carl W Langberg; Anna Laurell; Ulrika K Stierner; Olof Ståhl; Eva K Cavallin-Ståhl; Olbjørn H Klepp; Olav Dahl; Gabriella Cohn-Cedermark
Journal: J Clin Oncol Date: 2011-01-04 Impact factor: 44.544

4. Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma.

Authors: Mette S Mortensen; Mikkel Bandak; Maria G G Kier; Jakob Lauritsen; Mads Agerbaek; Niels V Holm; Hans von der Maase; Gedske Daugaard
Journal: Cancer Date: 2016-11-28 Impact factor: 6.860

5. Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.

Authors: Rune A W van de Wetering; Stefan Sleijfer; Darren R Feldman; Samuel A Funt; George J Bosl; Ronald de Wit
Journal: J Clin Oncol Date: 2018-02-01 Impact factor: 44.544

6. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.

Authors: Jorge Aparicio; Pablo Maroto; Xavier García del Muro; Josep Gumà; Alfonso Sánchez-Muñoz; Mireia Margelí; Montserrat Doménech; Romá Bastús; Antonio Fernández; Marta López-Brea; Josefa Terrassa; Andrés Meana; Purificación Martínez del Prado; Javier Sastre; Juan J Satrústegui; Regina Gironés; Lidia Robert; José R Germà
Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544

7. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

Authors: Jorge Aparicio; José R Germà; Xavier García del Muro; Pablo Maroto; José A Arranz; Alberto Sáenz; Agustín Barnadas; Joan Dorca; Josep Gumà; David Olmos; Romá Bastús; Joan Carles; Daniel Almenar; Miguel Sánchez; Luis Paz-Ares; Juan J Satrústegui; Begoña Mellado; Ana Balil; Marta López-Brea; Alfredo Sánchez
Journal: J Clin Oncol Date: 2005-10-31 Impact factor: 44.544